yahoo news alert 9/5/13
Raymond James, Jefferies, Bofa/ Merill, BNP All Upgrade NOK 9/4/13 post.
Seeking Alpha Market Currents 9/4/13
Nokia (NOK +2.1%) has been received four more upgrades - from Raymond James, Jefferies, BofA/Merrill,and BNP Paribas - on top of the upgrades it received yesterday.
lmao cheap cheap cheap
From BIOD Website
Biodel Announces Completion of Dosing in Phase 2 Clinical Trial of BIOD-123 in Patients With Type 1 Diabetes
Top-Line Data Expected in Third Quarter of 2013
DANBURY, Conn. (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today announced that all scheduled follow-up visits have been completed for patients enrolled in the Phase 2 clinical trial of BIOD-123, an investigational ultra-rapid-acting injectable mealtime insulin therapy.
Dr. Errol De Souza, president and chief executive officer of Biodel, stated: "Completing the BIOD-123 Phase 2 clinical trial is another significant milestone in the development of novel ultra-rapid-acting meal time insulins to aid patients and healthcare professionals in the treatment of diabetes. We look forward to sharing the top-line results by the end of this quarter
see ya there.
lock and loaded. Will hold this one,, many gains to come.
was out of town, this came out Fri. after hours
This ETF Holds Stocks Insiders Want to Own
ETFChannel.com ETFChannel.com, Contributor
MannKind Corp (NASD: MNKD), which makes up 0.59% of the iShares Nasdaq Biotechnology ETF (IBB), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $19,669,931 worth of MNKD, making it the #35 largest holding. The table below details the recent insider buying activity observed at MNKD:
Purchased Insider Title Shares Price/Share Value
06/30/2013 Matthew J. Pfeffer Corporate VP and CFO 7,448 $1.96 $14,598.08
06/30/2013 Diane Palumbo Vice President, Human Resource 1,610 $1.96 $3,155.60